CureVac N.V. ROA Ratio 2011-2026 | CVAC

Annual ROA Ratio CureVac N.V.

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-35.55	-8.59	-	-	-	-	-	-	-	-	-

All numbers in EUR currency

Indicator range from annual reports

Maximum	Minimum	Average
-8.59	-35.55	-22.07

Quarterly ROA Ratio CureVac N.V.

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-2.94	-2.94	-1.47	-1.47	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in EUR currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
-1.47	-2.94	-2.21

ROA Ratio of other stocks in the Biotechnology industry

Issuer	ROA Ratio	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	-20.13	-	2.43 %	$ 254 M	Germany
AgeX Therapeutics AGE	-275.96	-	-10.17 %	$ 12.2 K	USA
BioNTech SE BNTX	65.02	$ 96.09	-3.28 %	$ 27.2 B	Germany
I-Mab IMAB	7.43	-	-	$ 866 M	China
Akero Therapeutics AKRO	-30.52	-	-	$ 3.67 B	USA
Midatech Pharma plc MTP	-42.28	-	-18.52 %	$ 27.3 M	Britain
AlloVir ALVR	-35.68	-	4.14 %	$ 49.1 M	USA
Alexion Pharmaceuticals, Inc. ALXN	3.33	-	-	$ 40.3 B	USA
Biophytis SA BPTS	-89.6	-	-13.47 %	$ 169 M	France
Genfit SA GNFT	23.87	-	2.54 %	$ 160 B	France
EyeGate Pharmaceuticals, Inc. EYEG	-53.39	-	-1.52 %	$ 24.7 M	USA
Athira Pharma ATHA	-114.6	-	-	$ 269 M	USA
Applied Molecular Transport AMTI	-117.57	-	-	$ 10.1 M	USA
Ayala Pharmaceuticals AYLA	-489.29	-	-	$ 7.46 M	Israel
AstraZeneca PLC AZN	0.11	-	-	$ 96.9 B	Britain
Atreca BCEL	-62.67	-	-11.76 %	$ 5.79 M	USA
Berkeley Lights BLI	-43.36	-	-7.31 %	$ 87 M	USA
Calithera Biosciences CALA	-177.73	-	-10.95 %	$ 876 K	USA
Advaxis ADXS	-289.96	-	-9.65 %	$ 45.9 M	USA
CymaBay Therapeutics CBAY	-24.24	-	-	$ 3.45 B	USA
ChemoCentryx CCXI	-30.95	-	-	$ 3.74 B	USA
Институт стволовых клеток человека ISKJ	4.82	-	-	-	Russia
Caladrius Biosciences CLBS	-57.1	-	-16.75 %	$ 25.8 M	USA
Checkmate Pharmaceuticals CMPI	-77.89	-	-	$ 231 M	USA
Aeterna Zentaris AEZS	-10.45	-	5.93 %	$ 314 M	Canada
ACADIA Pharmaceuticals ACAD	19.07	$ 22.41	0.97 %	$ 3.71 B	USA
Brainstorm Cell Therapeutics BCLI	-1008.51	-	-2.5 %	$ 5.88 M	USA
Aeglea BioTherapeutics AGLE	-19.95	-	-	$ 1.01 B	USA
Burford Capital Limited BUR	5.51	$ 5.5	4.56 %	$ 875 M	Britain
Applied Genetic Technologies Corporation AGTC	-27.57	-	-	$ 26.5 M	USA
Deciphera Pharmaceuticals DCPH	-41.16	-	-	$ 2.18 B	USA
AIkido Pharma AIKI	-19.87	-	1.93 %	$ 17.4 M	USA
Cerus Corporation CERS	-7.04	$ 2.68	-1.65 %	$ 511 M	USA
Dynavax Technologies Corporation DVAX	2.77	-	-	$ 2.02 B	USA
Akouos AKUS	-31.09	-	0.23 %	$ 488 M	USA
Allakos ALLK	-76.23	-	-	$ 28.6 M	USA
Cardiff Oncology CRDF	-74.09	$ 1.68	1.52 %	$ 112 M	USA
Can-Fite BioPharma Ltd. CANF	-103.3	$ 3.41	2.71 %	$ 5.61 M	Israel
Eiger BioPharmaceuticals EIGR	-193.07	-	-9.21 %	$ 2.55 M	USA
Eloxx Pharmaceuticals ELOX	-170.74	-	-5.68 %	$ 8.28 M	USA
Ampio Pharmaceuticals AMPE	-150.49	-	-11.43 %	$ 502 K	USA
Applied Therapeutics APLT	-218.41	-	-	$ 8.42 M	USA
Aptose Biosciences APTO	-254.37	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	-97.25	-	-39.0 %	$ 4.57 M	USA
Aravive ARAV	-122.8	-	-13.39 %	$ 1.45 M	USA
Aridis Pharmaceuticals ARDS	-206.68	-	17.91 %	$ 11.1 M	USA
Arcutis Biotherapeutics ARQT	-3.73	$ 23.51	0.09 %	$ 2.99 B	USA
Allena Pharmaceuticals ALNA	-140.01	-	3.16 %	$ 1.9 M	USA
Eyenovia EYEN	-1358.28	-	49.81 %	$ 13.2 M	USA